Capricor Therapeutics
AJ Bergmann has held various finance-related positions at Capricor Therapeutics, Inc. since May 2011, including Chief Financial Officer, Vice President of Finance, Director of Finance and Operations, and Senior Financial Analyst. Prior to that, AJ worked as a Financial Analyst at Gettleson, Witzer & O'Connor from November 2009 to May 2011, and as a Client Accountant/Analyst from November 2008 to November 2009. AJ obtained an MBA in Entrepreneurship/Entrepreneurial Studies from USC Marshall School of Business in 2013, and a Bachelor of Science in Management with a minor in Finance from Providence College in 2008.
This person is not in any offices
Capricor Therapeutics
1 followers
Capricor Therapeutics, Inc. (NASDAQ: CAPR) is a clinical-stage biotechnology company focused on the development of cell and exosome-based therapeutics for the treatment and prevention of serious diseases.